
Veracyte’s Decipher Prostate Test Now Only Gene Expression Test in NCCN® Guidelines
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced that its Decipher Prostate Genomic Classifier is now the only gene expression test included in version 1 of the 2025…












